Rachel Webster
M.Sc., M.A. (Honors), D.Phil., Director, Healthcare Research & Data Analytics, Oncology and Biosimilars
Dr. Webster leads the therapy area in the production of syndicated market research reports and custom analysis of a wide range of oncology indications. She also provides sales and client support, helping biopharmaceutical companies uncover strategic opportunities through data-driven insights. Rachel has more than 15 years of experience in market forecasting and a broad knowledge of oncology indications and markets. Prior to joining the company, Dr. Webster was a research scientist at Immunocore in the target validation group. She has published numerous oncology market assessment articles in Nature Reviews Drug Discovery. Rachel received her doctorate, masters, and bachelors degrees in Biological Sciences from the University of Oxford.
